These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21225454)

  • 21. Activation of gamma-aminobutyric acid GAT-1 transporters on glutamatergic terminals of mouse spinal cord mediates glutamate release through anion channels and by transporter reversal.
    Raiteri L; Stigliani S; Patti L; Usai C; Bucci G; Diaspro A; Raiteri M; Bonanno G
    J Neurosci Res; 2005 May; 80(3):424-33. PubMed ID: 15789377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of excitation and inhibition signaling with the relative symptom expression of autism and psychosis-proneness: Implications for psychopharmacology.
    Ford TC; Abu-Akel A; Crewther DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():235-242. PubMed ID: 30075170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy.
    Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):525-35. PubMed ID: 9720980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal expressions of glutamate transporters and metabotropic glutamate receptor 1 in the spontaneously epileptic rat hippocampus.
    Guo F; Sun F; Yu JL; Wang QH; Tu DY; Mao XY; Liu R; Wu KC; Xie N; Hao LY; Cai JQ
    Brain Res Bull; 2010 Mar; 81(4-5):510-6. PubMed ID: 19853022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial glutamate transporters expression, glutamate uptake, and oxidative stress in an experimental rat model of intracerebral hemorrhage.
    Neves JD; Vizuete AF; Nicola F; Da Ré C; Rodrigues AF; Schmitz F; Mestriner RG; Aristimunha D; Wyse ATS; Netto CA
    Neurochem Int; 2018 Jun; 116():13-21. PubMed ID: 29530755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excitatory Amino Acid Transporters (EAATs): Glutamate Transport and Beyond.
    Magi S; Piccirillo S; Amoroso S; Lariccia V
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell therapy approaches to autism: a review of clinical trial data.
    Price J
    Mol Autism; 2020 May; 11(1):37. PubMed ID: 32448347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
    Hampson DR; Adusei DC; Pacey LK
    Biochem Pharmacol; 2011 May; 81(9):1078-86. PubMed ID: 21333634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caffeine alters glutamate-aspartate transporter function and expression in rat retina.
    de Freitas AP; Ferreira DD; Fernandes A; Martins RS; Borges-Martins VP; Sathler MF; Dos-Santos-Pereira M; Paes-de-Carvalho R; Giestal-de-Araujo E; de Melo Reis RA; Kubrusly RC
    Neuroscience; 2016 Nov; 337():285-294. PubMed ID: 27663541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytes: Glutamate transport and alternate splicing of transporters.
    Lee A; Pow DV
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1901-6. PubMed ID: 20883814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further studies of GABA and Glutamate imbalances in autism are important challenges for future research.
    Fernell E
    Acta Paediatr; 2019 Feb; 108(2):200-201. PubMed ID: 30359475
    [No Abstract]   [Full Text] [Related]  

  • 32. The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells.
    Ching J; Amiridis S; Stylli SS; Bjorksten AR; Kountouri N; Zheng T; Paradiso L; Luwor RB; Morokoff AP; O'Brien TJ; Kaye AH
    Oncotarget; 2015 Aug; 6(25):21301-14. PubMed ID: 26046374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis.
    Rosenblum LT; Trotti D
    Adv Neurobiol; 2017; 16():117-136. PubMed ID: 28828608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The glutamate transporter subtypes EAAT4 and EAATs 1-3 transport glutamate with dramatically different kinetics and voltage dependence but share a common uptake mechanism.
    Mim C; Balani P; Rauen T; Grewer C
    J Gen Physiol; 2005 Dec; 126(6):571-89. PubMed ID: 16316976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The glutamate transporter EAAT4 in rat cerebellar Purkinje cells: a glutamate-gated chloride channel concentrated near the synapse in parts of the dendritic membrane facing astroglia.
    Dehnes Y; Chaudhry FA; Ullensvang K; Lehre KP; Storm-Mathisen J; Danbolt NC
    J Neurosci; 1998 May; 18(10):3606-19. PubMed ID: 9570792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.
    Suchak SK; Baloyianni NV; Perkinton MS; Williams RJ; Meldrum BS; Rattray M
    J Neurochem; 2003 Feb; 84(3):522-32. PubMed ID: 12558972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
    Soni N; Reddy BV; Kumar P
    Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2.
    Boston-Howes W; Gibb SL; Williams EO; Pasinelli P; Brown RH; Trotti D
    J Biol Chem; 2006 May; 281(20):14076-84. PubMed ID: 16567804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins.
    Jackson M; Song W; Liu MY; Jin L; Dykes-Hoberg M; Lin CI; Bowers WJ; Federoff HJ; Sternweis PC; Rothstein JD
    Nature; 2001 Mar; 410(6824):89-93. PubMed ID: 11242047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the roles of glutamine synthetase, glutaminase, and glutamate decarboxylase autoantibodies in imbalanced excitatory/inhibitory neurotransmission as etiological mechanisms of autism.
    Hamed NO; Al-Ayadhi L; Osman MA; Elkhawad AO; Qasem H; Al-Marshoud M; Merghani NM; El-Ansary A
    Psychiatry Clin Neurosci; 2018 May; 72(5):362-373. PubMed ID: 29356297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.